Cargando…

Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II

Detalles Bibliográficos
Autores principales:	Falkai, Peter, Dombi, Zsófia Borbála
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476095/ https://www.ncbi.nlm.nih.gov/pubmed/37671286 http://dx.doi.org/10.3389/fpsyt.2023.1266566

Ejemplares similares

Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists
por: Németh, György, et al.
Publicado: (2022)

Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia
por: Rancans, Elmars, et al.
Publicado: (2022)

Real-Life Clinical Experience With Cariprazine: A Systematic Review of Case Studies
por: Csehi, Réka, et al.
Publicado: (2022)

Dopamine in Autism Spectrum Disorders—Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment
por: Mandic-Maravic, Vanja, et al.
Publicado: (2022)

Editorial: New trends in psychiatric research: Toward the clinical characterization of the individual case and the personalization of treatments
por: Sampogna, Gaia, et al.
Publicado: (2022)

Editorial: Brain and Somatization Symptoms in Psychiatric Disorders, Volume II
por: Fu, Xiaoya, et al.
Publicado: (2022)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Batinic, Borjanka, et al.
Publicado: (2021)

Editorial: Community series in ethics in psychiatry and psychotherapy — Volume II
por: Geppert, Cynthia M. A., et al.
Publicado: (2023)

Editorial: Community series in extreme eating behaviors—Volume II
por: Himmerich, Hubertus, et al.
Publicado: (2023)

The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample
por: Farrell, Christian, et al.
Publicado: (2020)

Antipsychotic-Induced Weight Gain and Clinical Improvement: A Psychiatric Paradox
por: Garcia-Rizo, Clemente
Publicado: (2020)

Editorial: Community series in mental health promotion and protection, volume II
por: Qureshi, Naseem Akhtar, et al.
Publicado: (2023)

Editorial: Non-invasive brain stimulation in psychiatric disorders: from bench to bedside, volume II
por: Hsu, Chih-Wei, et al.
Publicado: (2023)

Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study)
por: Ivanov, Stanislav V., et al.
Publicado: (2022)

Editorial: Community series - Purple Haze: issues on cannabis legalization, volume II
por: Potvin, Stéphane, et al.
Publicado: (2023)

Editorial: Psychiatric Disorder in Veterans
por: Pasinetti, Giulio M., et al.
Publicado: (2021)

The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study
por: Rancans, Elmars, et al.
Publicado: (2021)

Editorial: Community series in grief disorders: clinical, cultural, and epidemiological aspects, volume II
por: Smid, Geert E., et al.
Publicado: (2023)

Brain Derived Neurotrophic Factor and Cognitive Dysfunction in the Schizophrenia-Bipolar Spectrum: A Systematic Review and Meta-Analysis
por: Dombi, Zsófia B., et al.
Publicado: (2022)

Hippocampal Shape and Volume Changes with Antipsychotics in Early Stage Psychotic Illness
por: Mamah, Daniel, et al.
Publicado: (2012)

Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia
por: Peris, Lola, et al.
Publicado: (2021)

Editorial: Psychomotor Symptomatology in Psychiatric Illnesses
por: Walther, Sebastian, et al.
Publicado: (2015)

Editorial: Cognitive Enhancement in Psychiatric Disorders
por: Sumiyoshi, Tomiki, et al.
Publicado: (2019)

Editorial: Novel Technology in Psychiatric Rehabilitation
por: Tsang, Hector W. H., et al.
Publicado: (2022)

Editorial: Neuroinflammation, metabolism, and psychiatric disorders
por: Freyberg, Zachary, et al.
Publicado: (2022)

Editorial: Cardiometabolic disease and psychiatric disorders
por: Deste, Giacomo, et al.
Publicado: (2023)

Editorial: Neurocognitive deficits in psychiatric disorders
por: Yang, Jie
Publicado: (2023)

Successful treatment of dopamine dysregulation syndrome with dopamine D(2) partial agonist antipsychotic drug
por: Mizushima, Jin, et al.
Publicado: (2012)

The pharmacogenetics of the new-generation antipsychotics – A scoping review focused on patients with severe psychiatric disorders
por: Vasiliu, Octavian
Publicado: (2023)

Editorial: Community series in genetic mechanisms of biomarkers in schizophrenia, bipolar disorder and depression, volume II
por: Yin, Yubing, et al.
Publicado: (2023)

Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?
por: Mohr, Pavel, et al.
Publicado: (2022)

Editorial: Brain and Somatization Symptoms in Psychiatric Disorders
por: Fu, Xiaoya, et al.
Publicado: (2019)

Editorial: Problematic Gaming, Personality, and Psychiatric Disorders
por: Starcevic, Vladan, et al.
Publicado: (2020)

Editorial: Low-Intensity Interventions for Psychiatric Disorders
por: Sijbrandij, Marit, et al.
Publicado: (2020)

Editorial: Adult ADHD and other psychiatric disorders
por: Oliva, Francesco, et al.
Publicado: (2022)

Editorial: Psychiatric disorders of chronic physical diseases
por: Song, Dan, et al.
Publicado: (2023)

Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic—Volume II
por: El Hayek, Samer, et al.
Publicado: (2022)

Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic - Volume III
por: de Filippis, Renato, et al.
Publicado: (2023)

Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic - Volume IV
por: de Filippis, Renato, et al.
Publicado: (2023)

Editorial: Community series in ICD-11 personality disorders: utility and implications of the new model, volume II
por: Somma, Antonella, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kt1uas357382avuv2q3hva1qi7